Abstract

The phosphatidylinositol-specific phospholipase C (PLC) family is known to regulate physiological response through an increase in the levels of cytosolic Ca(2+). PLC hydrolyzes phosphatidylinositol-4, 5-bisphosphate (PIP2) to inositol-1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 releases the stored pool of Ca(2+). DAG stimulates protein kinase C (PKC) activity. An intriguing story is that some PLCs are also GTPase activating proteins (GAPs) or guanine nucleotide exchange factors (GEFs) to regulate the activity of their G protein. GEF and GAPs modulate the G protein GTPase cycle. GEFs catalyze the replacement of GDP with GTP to activate the G protein. GAPs accelerate the GTPase cycle to limit signaling upon removal of the activating ligand. It is not known whether GAP/GEF activity is coupled to the lipase activity of PLC, nor is it clear whether or how lipid factors may contribute to this synergistic interaction. While lipase activity is subject to allosteric regulation by mechanisms that include the signaling phospholipid, phosphatidic acid, regulation of the lipase associated GAP/GEF activity remains unexplored. This review explores the possibilities and evidence that support synergistic lipase-G protein regulatory activity in the PLC-β, PLC-δ, PLC-ε and PLC-γ subfamilies that may be mediated, in part, through phosphatidic acid. Understanding the full spectrum of PLC activities, and their regulation, is necessary to drive innovation in medicine by identifying novel targets.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call